The authors noted that while an association between cigarette smoking and TED has been well established, an association ...

The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s ...

Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of ...

Innovent Biologics (HKEX: 01801) has gained approval in China for Sycume (teprotumumab), the country’s first IGF-1R antibody ...

An eye exam can detect hidden health issues like diabetes, hypertension, and even brain tumors, making regular checkups vital ...

Currently, Batoclimab is being investigated globally for conditions such as generalized myasthenia gravis (gMG), thyroid eye ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

Innovent Biologics’ Sycume receives China NMPA approval for treatment of thyroid eye disease: San Francisco Monday, March 17, 2025, 16:00 Hrs [IST] Innovent Biologics, Inc, a wo ...

W ith spring and summer fast approaching, that means more time in the sun. While this is always a fun time, and getting ...

Lirum is developing LX-101 in oncology and autoimmune indications, including thyroid eye disease (TED). For more information on Lirum, please visit www.lirumtx.com. This press release contains ...